نتایج جستجو برای: like tyrosine kinase 3

تعداد نتایج: 2524300  

Journal: :iranian journal of pharmaceutical research 0
ramin shekarriz md, board certified hematologist-oncologist, assistant professor, department of hematology-oncology, cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran neda koulaeinejad pharmd, resident of clinical pharmacy, faculty of pharmacy, mazandaran university of medical sciences, sari, iran anahita nosrati md, board certified pathologist, assistant professor, department of pathology, imam khomeini hospital, mazandaran university of medical sciences, sari, iran ebrahim salehifar pharmd, board certified clinical pharmacist, associated professor, department of clinical pharmacy, pharmaceutical research center, mazandaran university of medical sciences, sari, iran

sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. it was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. it has several adverse reactions on multi organ systems including hematologic system. although the neutropenia and thrombocytopenia commonly happens as gra...

Journal: :international journal of hematology-oncology and stem cell research 0
gholamreza bahoush pediatric hematology-oncology department, ali-asghar children's hospital, iran university of medical sciences, tehran, iran mardavizh albouyeh pediatric hematology-oncology department, shohada general hospital, shahid-beheshti university of medical sciences, tehran, iran parvaneh vossough 1pediatric hematology-oncology department, ali-asghar children's hospital, iran university of medical sciences, tehran, iran

introduction: imatinib mesylate is a selective inhibitor of tk and is considered now to be the frontline therapeutic agent during the chronic phase of cml. we have evaluated the efficacy of it on children with chronic-phase of cml. patients and methods: in a clinical trial study over the past 3 years, 14 patients (8 females and 6 males, 2.5-14 years old) were admitted with a diagnosis of cml. s...

Journal: :iranian journal of pathology 2013
ali zare mehrjardi amineh vaghefi

background & objectives: anaplastic lymphoma kinase (alk) is a receptor tyrosine kinase involved in the genesis of several human cancers. alk was initially identified because of its involvement in anaplastic large cell lymphoma (alcl). alk is believed to foster tumorigenesis following activation by autocrine and/or paracrine growth loops. studies reveal that the presence of anti-alk antibod...

Journal: :avicenna journal of medical biotechnology 0

expression of receptor tyrosine kinase ror1 in a wide variety of cancers has emerged as a new era focusing on targeting this receptor in cancer therapy. our preliminary re-sults indicate the presence of a truncated transcript of ror1 in tumor cells. the trun-cated ror1 encompasses extracellular and transmembrane domains, lacking catalytic kinase domain (ror1-ecd). as enzyme activity is highly d...

2011
Susanne Schnittger

Size: 993 amino acids; 112804 Da; FLT3 is a class III receptor tyrosine kinase (RTK) structurally related to the receptors for platelet derived growth factor (PDGF), colony stimulating factor 1 (CSF1), and KIT ligand (KL).; these RTK contain five immunoglobulin-like domains in the extracellular region and an intracelular tyrosine kinase domain splitted in two by a specific hydrophilic insertion...

2011
Olivier Rosnet

993 amino acids; FLT3 is a class III receptor tyrosine kinase (RTK) structurally related to the receptors for platelet derived growth factor (PDGF), colony stimulating factor 1 (CSF1), and KIT ligand (KL); these RTK contain five immunoglobulin-like domains in the extracellular region and an intracelular tyrosine kinase domain split in two by a specific hydrophilic insertion (kinase insert); imm...

Background and Objective: Identification of cytogenetic and molecular changes plays an important role in acute myeloid leukemia (AML) patients. Thus, they are used in classification, prognosis and treatment of the disease. The CD123 expression and FLT3 gene mutations are also the variations that may assist in prognosis and treatment of patients with AML.Methods:</...

2017
Peter P. Ruvolo Huaxian Ma Vivian R. Ruvolo Xiaorui Zhang Hong Mu Wendy Schober Ivonne Hernandez Miguel Gallardo Joseph D. Khoury Jorge Cortes Michael Andreeff Sean M. Post

Nearly one-third of patients with acute myeloid leukemia have FMS-like tyrosine kinase 3 mutations and thus have poor survival prospects. Receptor tyrosine kinase anexelekto is critical for FMS-like tyrosine kinase 3 signaling and participates in FMS-like tyrosine kinase 3 inhibitor resistance mechanisms. Thus, strategies targeting anexelekto could prove useful for acute myeloid leukemia therap...

Journal: :iranian journal of pharmaceutical sciences 0
ajay gaur l.b.s. college of pharmacy, jaipur-302004, rajasthan, india arvind lal bhatia radiation biology laboratory, center for advanced studies, department of zoology, university of rajasthan, jaipur-302004, rajasthan, india.

genistein is a soya isoflavone, which is found naturally in legumes, such as soybeans and chickpeas. the intraperitoneal administration of the optimum dose (200 mg/kg) of genistein 24 h and 15 minbefore irradiation (8 gy at a dose rate of 1.02 gy/min) recovered the deficit in protein content (28.63±1.44%) and the dna content (21.61±8.19%) if an average of 5 intervals of autopsies 1st, 3rd, 7th,...

Ashish Kumar Rehni, Nirmal Singh, Seema Jindal,

Suppression of Akt (Protein kinase B) has been implicated in schizophrenia, the effect which has been documented to be reversed by tyrosine phosphatase inhibition. T hus, present study has been designed to study the effect of sodium orthovanadate, a tyrosine phosphatase inhibitor, on protracted methionine administration induced schizophrenia like behavior in rats. &nbsp; Schizophrenia...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید